The overexpression of SRSF3 or a degradation-resistant mutant was sufficient to prevent progressive liver disease in mice receiving a nonalcoholic steatohepatitis (NASH)-inducing diet30. This evidence concerns the gene SRSF3 and metabolic dysfunction-associated steatohepatitis.